Frankfurt - Delayed Quote EUR

X4 Pharmaceuticals, Inc. (48Q.F)

Compare
0.6300
-0.2320
(-26.91%)
At close: January 31 at 8:09:03 AM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
147,258.0000
155,586.0000
117,176.0000
122,871.0000
Total Liabilities Net Minority Interest
96,159.0000
81,535.0000
52,764.0000
50,072.0000
Total Equity Gross Minority Interest
51,099.0000
74,051.0000
64,412.0000
72,799.0000
Total Capitalization
105,669.0000
106,355.0000
97,551.0000
105,977.0000
Common Stock Equity
51,099.0000
74,051.0000
64,412.0000
72,799.0000
Capital Lease Obligations
3,711.0000
4,801.0000
5,851.0000
5,270.0000
Net Tangible Assets
33,748.0000
56,700.0000
47,061.0000
45,690.0000
Working Capital
99,214.0000
106,353.0000
73,855.0000
71,359.0000
Invested Capital
105,669.0000
107,670.0000
98,346.0000
105,977.0000
Tangible Book Value
33,748.0000
56,700.0000
47,061.0000
45,690.0000
Total Debt
58,281.0000
38,420.0000
39,785.0000
38,448.0000
Share Issued
167,434.5950
121,667.2500
28,127.6570
16,305.7310
Ordinary Shares Number
167,434.5950
121,667.2500
28,127.6570
16,305.7310
12/31/2020 - 2/14/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers